Biological functions and molecular mechanisms of LINC00961 in human cancer

References

• Bhattacharjee S, Nandi S. 2017. Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics. Iubmb Life. 69:929–937.
   PubMed Web of Science ®Google Scholar
• Cao R, Yuan L, Ma B, Wang G, Qiu W, Tian Y. 2020. An EMT-related gene signature for the prognosis of human bladder cancer. J Cell Mol Med. 24:605–617.
   PubMed Web of Science ®Google Scholar
• Chen D, Zhu M, Su H, Chen J, Xu X, Cao C. 2019. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma. J Cell Physiol. 234:7257–7265.
   PubMed Web of Science ®Google Scholar
• Chen WJ, Tang RX, He RQ, Li DY, Liang L, Zeng JH, Hu XH, Ma J, Li SK, Chen G. 2017. Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining. Oncotarget. 8:61282–61304.
   PubMedGoogle Scholar
• Ghafoor Q, Baijal S, Taniere P, O'Sullivan B, Evans M, Middleton G. 2018. Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors and Non-Small Cell Lung Cancer (NSCLC) -Advances in Molecular Diagnostic Techniques to Facilitate Targeted Therapy. Pathol Oncol Res. 24:723–731.
   PubMed Web of Science ®Google Scholar
• Guo Q, Li D, Luo X, Yuan Y, Li T, Liu H, Wang X. 2021. The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer. Front Immunol. 12:684807.
   PubMed Web of Science ®Google Scholar
• Hsu PC, Jablons DM, Yang CT, You L. 2019. Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC). Int J Mol Sci. 20(15):3821–3839.
   PubMed Web of Science ®Google Scholar
• Huang Z, Lei W, Tan J, Hu HB. 2018. Long noncoding RNA LINC00961 inhibits cell proliferation and induces cell apoptosis in human non-small cell lung cancer. J Cell Biochem. 119:9072–9080.
   PubMed Web of Science ®Google Scholar
• Jiang B, Liu J, Zhang YH, Shen D, Liu S, Lin F, Su J, Lin QF, Yan S, Li Y, et al. 2018. Long noncoding RNA LINC00961 inhibits cell invasion and metastasis in human non-small cell lung cancer. Biomed Pharmacother. 97:1311–1318.
   PubMed Web of Science ®Google Scholar
• Lee YT, Tan YJ, Oon CE. 2018. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 834:188–196.
   PubMed Web of Science ®Google Scholar
• Liu X, Shen X, Zhang J. 2022. Long non-coding RNA LINC00514 promotes the proliferation and invasion through the miR-708-5p/HOXB3 axis in cervical squamous cell carcinoma. Environ Toxicol. 37(1):161–170.
   PubMed Web of Science ®Google Scholar
• Lu XW, Xu N, Zheng YG, Li QX, Shi JS. 2018. Increased expression of long noncoding RNA LINC00961 suppresses glioma metastasis and correlates with favorable prognosis. Eur Rev Med Pharmacol Sci. 22:4917–4924.
   PubMed Web of Science ®Google Scholar
• McCoach CE, Blumenthal GM, Zhang L, Myers A, Tang S, Sridhara R, Keegan P, Pazdur R, Doebele RC, Kazandjian D. 2017. Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy. Ann Oncol. 28:2707–2714.
   PubMedGoogle Scholar
• Mehrpour LS, Arabpour M, Esmaeili R, Esmaeili R, Naghizadeh MM, Tavakkoly Bazzaz J, Shakoori A. 2020. Evaluation of the potential role of long non-coding RNA LINC00961 in luminal breast cancer: a case-control and systems biology study. Cancer Cell Int. 20:478.
   PubMed Web of Science ®Google Scholar
• Mu X, Mou KH, Ge R, Han D, Zhou Y, Wang LJ. 2019. Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR-367/PTEN axis. Int J Oncol. 55:708–720.
   PubMed Web of Science ®Google Scholar
• Pan LN, Sun YR. 2019. LINC00961 suppresses cell proliferation and induces cell apoptosis in oral squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 23:3358–3365.
   PubMed Web of Science ®Google Scholar
• Parolia A, Venalainen E, Xue H, Mather R, Lin D, Wu R, Pucci P, Rogalski J, Evans JR, Feng F, et al. 2019. The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program. Mol Oncol. 13:1121–1136.
   PubMed Web of Science ®Google Scholar
• Shang AQ, Wang WW, Yang YB, Gu CZ, Ji P, Chen C, Zeng BJ, Wu JL, Lu WY, Sun ZJ, Li D. 2019. Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p. Am J Physiol Gastrointest Liver Physiol. 317:G222–G232.
   PubMed Web of Science ®Google Scholar
• Shen S, Li K, Liu Y, Liu B, Ba Y, Xing W. 2020. Silencing lncRNA AGAP2-AS1 Upregulates miR-195-5p to Repress Migration and Invasion of EC Cells via the Decrease of FOSL1 Expression. Mol Ther Nucleic Acids. 20:331–344.
   PubMedGoogle Scholar
• Siegel RL, Miller KD, Jemal A. 2020. Cancer statistics, 2020. CA-Cancer J Clin. 70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Sui J, Zhao Q, Zhang Y, Liang G. 2022. Dysregulated LINC00961 Contributes to the Vitality and Migration of NSCLC Via miR-19a-3p/miR-19b-3p/miR-125b-5p. DNA Cell Biol. 41(3):319–329.
   PubMed Web of Science ®Google Scholar
• Takai M, Terai Y, Kawaguchi H, Ashihara K, Fujiwara S, Tanaka T, Tsunetoh S, Tanaka Y, Sasaki H, Kanemura M, et al. 2014. The EMT (epithelial-mesenchymal- transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer. J Ovarian Res. 7:76–83.
   PubMed Web of Science ®Google Scholar
• Wang J, Su Z, Lu S, Fu W, Liu Z, Jiang X, Tai S. 2018a. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta. 485:229–233.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhou J, Jiang C, Zheng J, Namba H, Chi P, Asakawa T. 2019. LNRRIL6, a novel long noncoding RNA, protects colorectal cancer cells by activating the IL-6-STAT3 pathway. Mol Oncol. 13:2344–2360.
   PubMed Web of Science ®Google Scholar
• Wang L, Kong W, Liu B, Zhang X. 2018b. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer. Biomed Pharmacother. 104:595–602.
   PubMed Web of Science ®Google Scholar
• Wu CT, Liu S, Tang M. 2019. Downregulation of linc00961 contributes to promote proliferation and inhibit apoptosis of vascular smooth muscle cell by sponging miR-367 in patients with coronary heart disease. Eur Rev Med Pharmacol Sci. 23:8540–8550.
   PubMed Web of Science ®Google Scholar
• Wu H, Dai Y, Zhang D, Zhang X, He Z, Xie X, Cai C. 2020. LINC00961 inhibits the migration and invasion of colon cancer cells by sponging miR-223-3p and targeting SOX11. Cancer Med. 9:2514–2523.
   PubMed Web of Science ®Google Scholar
• Xu J, Yang B, Wang L, Zhu Y, Zhu X, Xia Z, Zhao Z, Xu L. 2020. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression. Cell Prolif. 53:e12823.
   PubMed Web of Science ®Google Scholar
• Yan H, Li H, Silva MA, Guan Y, Yang L, Zhu L, Zhang Z, Li G, Ren C. 2019. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer. J Exp Clin Cancer Res. 38:356–368.
   PubMed Web of Science ®Google Scholar
• Yi C, Wan X, Zhang Y, Fu F, Zhao C, Qin R, Wu H, Li Y, Huang Y. 2018. SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis. Int J Biochem Cell Biol. 102:138–150.
   PubMed Web of Science ®Google Scholar
• Yin J, Liu Q, Chen C, Liu W. 2019. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1. J Cell Physiol. 234:17589–17599.
   PubMed Web of Science ®Google Scholar
• Zhang L, Shao L, Hu Y. 2019b. Long noncoding RNA LINC00961 inhibited cell proliferation and invasion through regulating the Wnt/β-catenin signaling pathway in tongue squamous cell carcinoma. J Cell Biochem. 120:12429–12435.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Mao L, Li X. 2020. Long noncoding RNA HCG11 inhibited growth and invasion in cervical cancer by sponging miR-942-5p and targeting GFI1. Cancer Med. 9(19):7062–7071.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Shao L, Wang Y, Luo X. 2019a. MicroRNA-501-3p restricts prostate cancer growth through regulating cell cycle-related and expression-elevated protein in tumor/cyclin D1 signaling. Biochem Biophys Res Commun. 509:746–752.
   PubMed Web of Science ®Google Scholar
• Zheng C, Li X, Ren Y, Yin Z, Zhou B. 2019. Long Noncoding RNA RAET1K Enhances CCNE1 Expression and Cell Cycle Arrest of Lung Adenocarcinoma Cell by Sponging miRNA-135a-5p. Front Genet. 10:1348.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Guo J, Huang W, Yu X, Xu C, Long X. 2020. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2. Mol Oncol. 14:2231–2250.
   PubMed Web of Science ®Google Scholar